Skip to main content

Table 1 Baseline Characteristics of Single lung transplant subjects

From: Differences in airway microbiome and metabolome of single lung transplant recipients

S.
No
Age Gender Side of Transplant Duration of Transplant (months) Pre-transplant diagnosis IS Prophylactic Antibiotic BAL Culture BAL cell count differential CLAD at sample collection
(Y/N)
CLAD at follow-up (2 years)
(Y/N)
1 64 M Left 20 IPF Tac, Pred, Aza Val, Itra, Dapsone, Negative M-99%, N-1% N N
2 57 M Right 13 CTD-ILD Tac, Pred, MMF TMP/SMX, Val, Vori Negative M-95%, L-3%, N- 2% Y Y
3 64 M Left 30 IPF Tac, Pred, MMF Azithro, TMP/SMX, Val Negative M-10%, L-40%, N- 50% N Y
4 69 M Left 31 IPF Tac, Pred, Aza Dapsone, Azithro, Negative M-93%, L-5%, N-2% N Y
5 59 F Right 18 IPF Tac, Aza Pred TMP/SMX Negative M-38%, L- 54%, N 8% N Y
6 62 M Left 79 IPF Tac, Pred Dapsone 1000 CFU normal flora M-58%, L-3%, N-39% Y Y
  1. Abbreviations: IS Immunosuppression, Azithro Azithromycin; CLAD Chronic Lung Allograft Dysfunction, IPF Idiopathic pulmonary fibrosis, CTD-ILD Connective tissue disease related interstitial lung disease, Aza Azathioprine, Itra itraconazole, MMF Mycophenolate mofetil, Pred Prednisone, Tac Tacrolimus, TMP/SMX Trimethoprim–sulfamethoxazole, Val Valganciclovir, Vori Voriconazole, M Macrophages, L Lymphocytes, N Neutrophils